Israeli startup Virility Medical, which has developed a patch for the treatment of premature ejaculation, has raised $10 million from Migdal Insurance ($8 million) and Arkin investments ($2 million). Virility Medical, which is a portfolio company of Almeda Ventures, is planning to raise $40 million.
The company treats premature ejaculation by using a drug-free, skin patch based on EMS (Electrical Muscle Stimulation) in contrast to other medical interventions such as medication, which can cause side effects. The skin patch, which is clinically proven to prolong sexual intercourse, FDA-cleared and CE – mark approved.
RELATED ARTICLES
Premature ejaculation patch co Virility raising $8m
Virility’s marketing strategy in the US and Europe focuses on selling the product via online platforms directly to the consumer, and to lead drugstores such as Boots, Walgreens, CVS, Walmart, and more.
About 25% of the male population suffers from premature ejaculation, which is the most common sexual dysfunction for men.
The company was founded in the NGT3 technological incubator in Nazareth by CTO Tal Gollan and is currently managed by CEO David Salton.
Salton said, “Such rapid securing of this investment, given current market conditions which are characterized by great uncertainty, indicates the business potential inherent in Virility.”
Published by Globes, Israel business news – en.globes.co.il – on July 21 2022.
© Copyright of Globes Publisher Itonut (1983) Ltd., 2022.
Stay connected with us on social media platform for instant update click here to join our Twitter, & Facebook
We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.
For all the latest Business News Click Here
For the latest news and updates, follow us on Google News.
Denial of responsibility! NewsAzi is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.
